Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$6.76 - $46.98
Next Earnings Date
May 06 2025
Next Earnings Date
May 06 2025
Latest price
Market Cap | $3.08B |
EV | $2.71B |
Shares Outstanding | 99.19M |
Beta | 0.58 |
Analyst Rating | BUY |
Analyst Target Price | $50.50 |
P/E 2025E | - |
P/Revenue 2025E | 116.35x |
Revenue | - |
EPS | 11.70% |
Operating Cash Flow | -16.60% |
Free Cash Flow | -15.00% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | 77.80% |
Gross Margin 2025E | 57.67% |
Net Profit Margin 2025E | -963.91% |
ROE 2025E | -56.53% |
ROCE 2024 | -82.95% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Scholar Rock Holding Corporation
SRRK
Sector
Healthcare
Industry
Biotechnology
CEO
Backstrom, Jay
Employees
128
Website
scholarrock.comIPO Date
2018-05-25
Headquarters
301 Binney Street, 3rd Floor, Cambridge, Massachusetts, 02142, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved